The Duke Myasthenia Gravis Clinic Registry: II . Analysis of outcomes
Muscle & Nerve · 2023
DOI: 10.1002/mus.27794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2023. Verfasst von Donald B Sanders und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Division, Department of Neurology, Duke University Medical Center, Durham, North Carolina. Hauptthemen laut MEDLINE: Myasthenia Gravis, Thymus Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction/Aims The Duke Myasthenia Gravis (MG) Clinic Registry contains comprehensive physician‐derived data on patients with MG seen in the Duke MG Clinic since 1980. The aim of this study was to report outcomes in patients seen in the clinic and treated according to the International Consensus Guidance statements.
Methods
This is a retrospective cohort study of patients initially seen after 2000 and followed for at least 2 years in the clinic. Treatment goal (TG) was defined as achieving MGFA post‐intervention status of “minimal manifestations” or better; PIS was determined by the treating neurologist. Time‐to‐event analysis, including Cox proportional hazards modeling, was performed to assess the effect of sex, acetylcholine receptor antibody (AChR‐Ab) status, age at disease onset, distribution (ocular vs generalized), thymectomy, and thymoma on the time to achieve TG.
Results
Among the 367 cohort patients, 72% achieved TG (median time less than 2 years). A greater proportion of patients with AChR‐Abs and thymectomy achieved TG and they did so sooner than patients without these antibodies or thymectomy. Otherwise, there were no significant differences in these findings within the tested subgroups. The disease duration at the first Duke Clinic visit was shorter in patients who achieved TG than in those who did not.
Discussion
These results demonstrate outcomes that can be achieved in patients with MG treated according to the current Consensus Guidance statements. Among other things, they can be used to determine the added value and potential role of new treatment modalities developed since 2018.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuromuscular Division, Department of Neurology, Duke University Medical Center, Durham, North Carolina.
ORCID-Profile: Donald B Sanders, Shruti M Raja
Zitieren
APA
Sanders, D. B., Lutz, M. W., Raja, S. M., Juel, V. C., Guptill, J. T., Hobson-Webb, L. D., & Massey, J. M. (2023). The Duke Myasthenia Gravis Clinic Registry: II . Analysis of outcomes. Muscle & Nerve. https://doi.org/10.1002/mus.27794
Vancouver
Sanders DB, Lutz MW, Raja SM, Juel VC, Guptill JT, Hobson-Webb LD, et al. The Duke Myasthenia Gravis Clinic Registry: II . Analysis of outcomes. Muscle & Nerve. 2023. doi:10.1002/mus.27794
BibTeX
@article{Sanders2023,
author = {Sanders, Donald B and Lutz, Michael W and Raja, Shruti M and Juel, Vern C and Guptill, Jeffrey T and Hobson-Webb, Lisa D and Massey, Janice M},
title = {The Duke Myasthenia Gravis Clinic Registry: II . Analysis of outcomes},
journal = {Muscle & Nerve},
year = {2023},
doi = {10.1002/mus.27794}
}
EUVIMED